Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MacuCLEAR and Mystic Successfully Complete Phase Ib Clinical Trial for Macular Degeneration
Pipeline Review
Saturday, October 10, 2009 - 12:04pm
tags:
MacuClear, Mystic, macular degeneration
J&J wheels and deals, awaits new product approvals
Yahoo/AP
Saturday, October 10, 2009 - 12:02pm
tags:
JNJ
Analyst trims Bristol-Myers Squibb to 'Neutral'
Yahoo/AP
Saturday, October 10, 2009 - 12:02pm
tags:
Bristol-Myers Squibb
Locus, Novartis to collaborate
bizjournals.com
Saturday, October 10, 2009 - 12:01pm
tags:
Locus, Novartis
Sanofi Vaccine Proves Beneficial
Yahoo/Zacks
Saturday, October 10, 2009 - 11:56am
tags:
Sanofi, H1N1
House Moves Closer to Combined Health Measure With Tax Changes
Bloomberg
Friday, October 9, 2009 - 10:18am
tags:
healthcare reform
What the Bosses of AZ, Novartis and Schering Didn't Say in Their Healthcare Roundtable
BNET Pharma
Friday, October 9, 2009 - 10:17am
tags:
Pharma CEOs, David Brennan, AstraZeneca, Novartis, Daniel Vasella, Fred Hassan, Schering Plough
Hemispherx CEO Spills Ampligen Beans to Stock Cheerleader
TheStreet.com
Friday, October 9, 2009 - 10:13am
tags:
Hemispherx, Ampligen
Inovio Biomedical: DNA Vaccine Delivery Innovator
Seeking Alpha
Friday, October 9, 2009 - 10:11am
tags:
DNA, vaccines, Inovio, Merck
The new biotech paradigm: Survive and stay independent
Fierce Biotech
Friday, October 9, 2009 - 10:08am
tags:
biotech
Drug stocks mixed; Avanir jumps on MS news
Marketwatch
Friday, October 9, 2009 - 10:07am
tags:
Avanir, MS, drug stocks
Industry Payments to Surgeons, Revisited
WSJ Online
Friday, October 9, 2009 - 10:02am
tags:
physician payments, medical devices
Sanofi, Merck Among Global Bidders for iNova, Review Reports
Bloomberg
Friday, October 9, 2009 - 10:00am
tags:
iNova, Australia, Merck KGaA, Sanofi
AstraZeneca Promoted Seroquel as ‘Weight Neutral’
Bloomberg
Friday, October 9, 2009 - 9:59am
tags:
AstraZeneca, Seroquel, antipsychotics
Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Yahoo/AP
Friday, October 9, 2009 - 9:58am
tags:
Fusilev, FDA, colon cancer, Spectrum Pharmaceuticals
Acorda’s MS Drug May Need More Study, U.S. FDA Says
Bloomberg
Friday, October 9, 2009 - 9:29am
tags:
Acorda Therapeutics, MS, multiple sclerosis, Fampridine-SR
Medicines Co. sues Teva and APP Pharma over patents supporting anti-clotting drug Angiomax
Yahoo/AP
Friday, October 9, 2009 - 9:27am
tags:
anti-clotting, Angiomax, APP, Teva Pharmaceuticals, Medicines Company
5-Star Stocks Poised to Pop: Novo Nordisk
Motley Fool
Friday, October 9, 2009 - 8:24am
tags:
Novo Nordisk
3 Slow-and-Steady Healthcare Stocks
Investopedia
Friday, October 9, 2009 - 8:21am
tags:
JNJ, drug stocks, Abbott Laboratories, Boston Scientific
J&J earnings expected to be weighed down by generics
Marketwatch
Friday, October 9, 2009 - 8:19am
tags:
JNJ, earnings, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.